Long non-coding RNAs in hepatocellular carcinoma

• Published in: Pathology, research and practice Vol. 248; p. 154604
• Main Authors: Ge, Wen-jun, Huang, Huan, Wang, Tao, Zeng, Wei-hong, Guo, Min, Ren, Chen-ran, Fan, Ting-yu, Liu, Fang, Zeng, Xi
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.08.2023
• Subjects: Autophagy; Chemotherapy resistance; Hepatocellular carcinoma; LncRNAs; Hepatocellular carcinoma; Chemotherapy resistance; Autophagy; LncRNAs
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1016/j.prp.2023.154604

Long noncoding RNAs (lncRNAs) refer to a class of RNAs greater than 200 nucleotides in length, most of which are considered unable to encode proteins, thus deemed to be junk genes formerly. But with emerging studies about lncRNAs coming out in recent years, it is much more clearly depicted that they can regulate gene expression at different levels, with various mechanisms, thus participating in diverse biological or pathological processes, including complicated tumor-associated pathways. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, the third leading cause of cancer-related mortality worldwide, which has been found to tightly associate with aberrant expression of a variety of lncRNAs regulating tumor proliferation, invasion, drug resistance, and so on, making it a potential novel tumor marker and therapeutic target. In this review, we highlight a few lncRNAs that are closely related to the occurrence and progression of HCC and try to cover their multifarious roles from different layers.